Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS/Caremark merger

This article was originally published in The Tan Sheet

Executive Summary

Caremark Rx announces Jan. 7 its merger with CVS will "result in new and broader disease management and wellness services delivered through Caremark's and CVS's combined 21,000 pharmacists and nurse practitioners along with Caremark's analytic capabilities and clinical programs." The Nashville, Tenn.-based firm says its pending combination with CVS will "define and lead the next evolution of the pharmaceutical services industry." In response to a lawsuit filed by Express Scripts, CVS says: "This is just another desperate attempt by Express Scripts to derail a merger that not only has the complete support of both the CVS and Caremark boards, but also has received strong support from customers and employees of both companies." Caremark refused a $26.5 bil. offer Express Scripts made in December...

You may also be interested in...



CVS/Caremark deal closes

CVS and Caremark announce March 22 they have closed their merger. The combined company renamed CVS/Caremark Corporation will "commence a cash tender offer in approximately five business days for $150 mil. or about 10 percent of its outstanding shares at a fixed price of $35 per share," according to a release. The combined company will trade on the NYSE under the symbol CVS, according to the firms. Caremark announced Jan. 7 its planned merger with CVS (1"The Tan Sheet" Jan. 15, 2007, In Brief). Also on March 22, CVS/Caremark announces its board of directors. The 14-member board was evenly split among designees from CVS and from Caremark, the company says in a release. Thomas M. Ryan will continue to serve as president and CEO...

CVS/Caremark merger moves forward

Both CVS and Caremark Rx announce the week of March 12 shareholders approved of their merger. CVS says in a March 16 release the transaction is expected to close the week of March 19. "The tender offer for 150 million of CVS/Caremark's outstanding shares will commence approximately five business days after the closing," CVS says in a release. The special cash dividend of $7.50 per share will be payable at or after closing of the merger, CVS says. Caremark says in a March 16 release the merger will close subject to official certification of the voting results by independent inspectors. Caremark Rx announced in January the merger would "result in new and broader disease management and wellness services" (1"The Tan Sheet," Jan. 15, 2007, In Brief)...

Unfairly Hit By Influencer Assassins? Now Could Be Your Chance To Mobilize The FTC

Brands unfairly maligned by powerful influencers, strictly on behalf of paying competitors, could have occasion to broach the subject with the US Federal Trade Commission, which seeks comment on its “Endorsement Guides” in an increasingly complex and competitive, digitized advertising environment.    

Topics

UsernamePublicRestriction

Register

PS100112

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel